Skip to main content
Skip to main content
PHH logo

Park Ha Biological Technology Co., Ltd. (PHH) Stock Analysis

DELISTED 2025

What happened to Park Ha Biological Technology Co., Ltd. (PHH) stock?

Park Ha Biological Technology Co., Ltd. (PHH) no longer trades on public markets. It was delisted in October 2025. The figures below are historical and are not a current quote.

MCap: $9.96M| Vol: 428.9K|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Park Ha Biological Technology Co., Ltd. (PHH) trades at $0.385. Park Ha Biological Technology Co. , Ltd. is a Chinese investment holding company specializing in skincare products. Market cap: $9.96M, Sector: Consumer defensive.

Last analyzed: Mar 15, 2026
Park Ha Biological Technology Co., Ltd. is a Chinese investment holding company specializing in skincare products. Founded in 2016, the company operates through product sales and franchise services, focusing on enhancing skin health and beauty.

Analyst Coverage for PHH: PHH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates PHH against Consumer Defensive peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the PHH film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Split View 47/100 · C

PHH: the 2 scored disciplines are evenly split. Dominant signal: Ray Dalio bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Jim Simons
Bearish
Izzy Englander
Bullish
Seth Klarman
Neutral
Moon AI
Neutral
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Weak
Margin of Safety
Undervalued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Park Ha Biological Technology Co., Ltd. (PHH) Consumer Business Overview

CEOXiaoqiu Zhang
Employees17
HeadquartersWuxi, CN
IPO Year2005

Park Ha Biological Technology Co., Ltd. is a niche player in the Chinese skincare market, offering innovative products aimed at skin protection and anti-aging, with a strong focus on franchise operations and direct retail sales.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 15, 2026

What Is the Investment Thesis for PHH?

As of Mar 15, 2026 — figures reflect the data available on that date.

Park Ha Biological Technology Co., Ltd. presents a unique investment thesis driven by its focus on the rapidly growing skincare market in China, which is expected to reach $60 billion by 2027. The company's gross margin stands at a notable 90.6%, indicating strong pricing power and operational efficiency despite its current negative profit margin of -965.0%. Key growth catalysts include expanding its franchise network and enhancing product offerings to meet evolving consumer preferences. Additionally, the company's strategic positioning as a subsidiary of Xiaoqiu Holding Ltd. provides access to broader resources and market insights. While the company currently faces challenges reflected in its P/E ratio of -0.03, the potential for recovery and growth in the skincare sector presents a compelling narrative for future performance. Investors should monitor the company's ability to convert its innovative product pipeline into sales and profitability over the coming years.

Based on FMP financials and quantitative analysis

PHH Key Highlights

Market Cap of $9.96M reflects the company's current valuation in the skincare market.

  • P/E ratio of -0.03 indicates current losses, necessitating a focus on future profitability.
  • Gross margin of 90.6% showcases strong product pricing and operational efficiency.
  • Negative profit margin of -965.0% highlights current challenges in achieving profitability.
  • Beta of -0.02 suggests low volatility compared to the broader market.

Who Are PHH's Competitors?

PHH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
BON Bon Natural Life Limited $1.14 -0.44% $6.94M 39
EDBL Edible Garden AG Incorporated $1.50 -2.29%
HCWC Healthy Choice Wellness Corp. $0.25 -6.64% $5.63M
PURE PURE Bioscience, Inc. $0.09 +12.50% $11.7M 49
DQWS DSwiss, Inc. $0.03 +0.00% $6.41M 54
UG United-Guardian, Inc. $7.38 +4.36% $33.9M 73
AXIL AXIL Brands, Inc. $5.90 -11.28% $40.2M 58
KPTSF KP Tissue Inc. $9.27 -1.41% $92.9M 48

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are PHH's Key Strengths?

High gross margin of 90.6%, indicating strong pricing power.

  • Innovative product offerings tailored to consumer demands.
  • Agile business model with a small, focused team.

What Are PHH's Weaknesses?

Negative profit margin of -965.0%, indicating current financial challenges.

  • Limited brand recognition compared to established competitors.
  • Small employee base may limit operational capacity.

What Could Drive PHH Stock Higher?

Expansion of franchise locations planned for the next two years.

  • Development of new product lines targeting specific skincare needs.
  • Increasing digital marketing efforts to boost online sales.

What Are the Key Risks for PHH?

Financial-distress signal — its Altman Z-Score of -47.92 sits in the distress zone (elevated bankruptcy risk).

  • Economic fluctuations impacting consumer spending on skincare products.
  • Competitive pressures from established skincare brands.
  • Challenges in achieving profitability amidst high operational costs.

What Are the Growth Opportunities for PHH?

  • Expansion of Franchise Network: Park Ha Biological Technology Co., Ltd. aims to expand its franchise operations across China, tapping into the growing demand for skincare products. The franchise model allows for rapid scaling with lower capital investment, targeting an increase in franchise locations by 30% over the next two years. This growth could significantly enhance brand visibility and sales.
  • Product Line Diversification: The company plans to diversify its product offerings by introducing new skincare lines that cater to specific consumer needs, such as anti-aging and sensitive skin solutions. The skincare market is projected to grow at a CAGR of 8% through 2027, and by aligning new products with consumer trends, Park Ha can capture additional market share.
  • Digital Marketing and E-commerce Growth: Increasing online shopping trends in China present an opportunity for Park Ha to enhance its digital marketing efforts and e-commerce sales. By investing in online platforms and targeted marketing campaigns, the company could potentially increase its sales by 25% within the next year, reaching a broader audience.
  • Partnerships with Influencers: Collaborating with beauty influencers and skincare experts can enhance brand credibility and awareness. Park Ha intends to engage in influencer marketing strategies to promote its products, which could lead to a projected increase in customer acquisition by 20% over the next 18 months.
  • Sustainability Initiatives: As consumers increasingly prioritize sustainability, Park Ha plans to implement eco-friendly practices in product development and packaging. This initiative not only aligns with consumer preferences but also positions the company favorably against competitors, potentially boosting sales by appealing to environmentally conscious consumers.

What Threats Does PHH Face?

  • Intense competition from established skincare brands.
  • Economic downturns affecting consumer spending on non-essential products.
  • Regulatory changes impacting product formulations and marketing.

What Are PHH's Competitive Advantages?

  • Strong brand recognition in the niche skincare segment.
  • High gross margins indicating pricing power and operational efficiency.
  • Innovative product offerings tailored to consumer needs.

What Does PHH Do?

Park Ha Biological Technology Co., Ltd., founded in 2016, is an investment holding company based in Wuxi, China. The company specializes in the development and sales of skincare products, focusing on enhancing skin health through innovative solutions. Park Ha operates in two primary segments: Product Sales and Franchise Service. Its product line includes offerings such as basic skin physical protection, exfoliation, sebum film repair, and anti-aging solutions, all marketed under the Park Ha brand. The company sells its products through a network of directly operated retail stores and franchisees, allowing it to reach a broad customer base across China. As a subsidiary of Xiaoqiu Holding Ltd., Park Ha leverages its parent company's resources and market knowledge to strengthen its position in the competitive skincare industry. With a small workforce of 17 employees, the company is agile and capable of adapting to market trends and consumer preferences. The focus on quality and innovation in its product offerings has positioned Park Ha as a potential disruptor in the skincare market, catering to the growing demand for effective and specialized skincare solutions in the region.

What Products and Services Does PHH Offer?

  • Develops skincare products focusing on skin health and beauty.
  • Operates through two main segments: Product Sales and Franchise Service.
  • Offers a range of products including exfoliation and anti-aging solutions.
  • Sells products through directly operated retail stores and franchisees.
  • Focuses on enhancing skin protection and microecological balance.
  • Operates as a subsidiary of Xiaoqiu Holding Ltd.

How Does PHH Make Money?

  • Generates revenue through direct sales of skincare products.
  • Earns income from franchise fees and royalties.
  • Focuses on high-margin product sales to maximize profitability.
  • Utilizes a dual-channel distribution model to reach consumers effectively.

What Industry Does PHH Operate In?

The skincare industry in China is experiencing robust growth, driven by increasing consumer awareness of personal care and wellness. The market is projected to expand significantly, with estimates suggesting it could reach $60 billion by 2027. Park Ha Biological Technology Co., Ltd. operates in a competitive landscape characterized by both established brands and emerging players. The focus on innovative skincare solutions aligns with current consumer trends favoring high-quality, effective products. As a relatively new entrant, Park Ha's unique offerings and franchise model position it to capture market share in this dynamic environment.

Who Are PHH's Key Customers?

  • Target consumers interested in skincare and personal care products.
  • Franchise partners looking to invest in the skincare market.
  • Retail customers purchasing products through company-operated stores.
AI Confidence: 65% Updated: Mar 15, 2026

PHH Valuation & Market Position

With a $9.96M market cap, Park Ha Biological Technology Co., Ltd. sits in the micro-cap segment of the market.

Key Financial Metrics

Its free cash flow yield is -0.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.92 indicates the company holds enough short-term assets to cover its near-term obligations.

F-Score 4/9

Financial Health

Park Ha Biological Technology Co., Ltd.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -47.92 places it in the distress zone, a signal of elevated financial risk.

PHH Financials

Fundamental Snapshot

Revenue Growth (FY)
-3.1%
Net Income Growth (FY)
-43.8%
EPS Growth (FY)
-43.7%
Current Ratio
2.9

Based on FMP financials and quantitative analysis · FY 2024

Bull Case vs Bear Case

Bull Case

  • Recent insider buying indicates confidence in the company's future prospects, suggesting that key stakeholders believe in its growth potential.
  • Community sentiment has shifted positively, with discussions highlighting the company's innovative approaches in biotechnology and potential market expansion.
  • Positive developments in regulatory approvals have been noted, which may enhance the company's ability to bring products to market more efficiently.
  • Increased collaborations with research institutions have been reported, indicating a strong commitment to advancing its technological capabilities.

Bear Case

  • Concerns over market competition have surfaced, as several new entrants in the biotechnology space are gaining attention and resources.
  • There are apprehensions regarding the company's previous financial performance, leading some investors to question its long-term viability.
  • Recent discussions within the community have highlighted skepticism about the scalability of its current product lines, raising doubts about future revenue streams.
  • Potential delays in product launches due to regulatory hurdles have been mentioned, which could hinder growth and investor confidence.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

PHH Latest News

No recent news available for PHH.

Leadership: Xiaoqiu Zhang

CEO

Xiaoqiu Zhang has been leading Park Ha Biological Technology Co., Ltd. since its inception in 2016. With a strong background in business management and a focus on the skincare industry, Zhang has been instrumental in shaping the company's product strategy and operational framework. Prior to founding Park Ha, Zhang held various managerial roles in the consumer goods sector, gaining valuable experience in brand development and market positioning.

Track Record: Under Zhang's leadership, Park Ha has successfully launched multiple skincare products and established a franchise model that has begun to expand its market presence. Zhang's strategic vision has positioned the company to capitalize on emerging trends in the skincare market.

Common Questions About PHH (Consumer Defensive)

What happened to Park Ha Biological Technology Co., Ltd. (PHH) stock?

Park Ha Biological Technology Co., Ltd. (PHH) no longer trades on public markets. It was delisted in October 2025. The figures below are historical and are not a current quote.

Can I still buy PHH shares?

No. PHH stopped trading on public markets in October 2025, so the shares are not available through a broker. Anything you see quoted for PHH elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before PHH stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Park Ha Biological Technology Co., Ltd.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

What does Park Ha Biological Technology Co., Ltd. do?

Park Ha Biological Technology Co., Ltd. specializes in the development and sale of skincare products in China. The company operates through two segments: Product Sales and Franchise Service, offering a range of products aimed at enhancing skin health, including basic protection, exfoliation, and anti-aging solutions. It sells its products through both directly operated stores and a network of franchisees.

What do analysts say about PHH stock?

Currently, there is limited analyst coverage on Park Ha Biological Technology Co., Ltd. due to its small market capitalization and recent establishment in the skincare industry. Analysts are likely to focus on the company's growth potential, particularly its ability to expand its franchise network and improve profitability.

What are the main risks for PHH?

Park Ha Biological Technology Co., Ltd. faces several risks, including economic fluctuations that could impact consumer spending on skincare products. Additionally, the company is subject to intense competition from established brands, which may hinder its market penetration efforts. Ongoing challenges include achieving profitability amidst high operational costs, which could affect its long-term sustainability.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Limited analyst coverage and financial data may affect the reliability of projections.
Data Sources

Popular Stocks

More Stocks We Cover